From the conference website: “As 2011 progresses there are both new opportunities and new challenges for biotech companies, pharmaceutical partners and investors. C21 provides a platform to network with your peers, learn from new business models and pre-schedule face-to-face meetings with the partners and investors you need to succeed. With podium presentations, leadership sessions and two-full days of face-to-face partnering meetings C21 is an opportunity you shouldn’t miss.”